Sort
11,323 grants matching “glioblastoma”
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$553,721John K. Wiencke · University Of California, San Francisco · P50 · FY2018 · CA
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate
$553,640Lawrence D Recht · Stanford University · R01 · FY2016 · CA
Advancing Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
$553,502Eric Claude Leuthardt · Washington University · R01 · FY2023 · CA
Multigenic copy number alterations
$553,157Scott Powers · State University New York Stony Brook · R01 · FY2021 · CA
Enhancing MAPK-targeted Therapy in PDX Models of BRAF-Mutant Pediatric Brain Tumors
$553,149Sandeep Burma · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Defining cellular states of quiescence in human brain tumors
$553,130Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2021 · NS
Targeting EphA2 in Glioblastoma
$552,859Bingcheng Wang · Case Western Reserve University · R01 · FY2016 · NS
Project 1
$552,743David J Odde · University Of Minnesota · P01 · FY2023 · CA
Project 1
$552,743David J Odde · University Of Minnesota · P01 · FY2022 · CA
Clinical efficacy of the antitumor agent ONC201 in GBM
$552,548Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2016 · CA
Pre-Clinical Novel Radiosensitizer Evaluation Program for Brain Tumors
$552,341Jann N Sarkaria · Mayo Clinic Rochester · U01 · FY2022 · CA
AZD2171 and chemoradiation for newly diagnosed glioblastoma
$552,172Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2007 · CA
Multigenic copy number alterations
$552,016Scott Powers · State University New York Stony Brook · R01 · FY2017 · CA
Control of Protein Translation in Cancer Pathogenesis
$551,829Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · U01 · FY2006 · CA
Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
$551,600James M Markert · University Of Alabama At Birmingham · R01 · FY2020 · CA
Improved whole-brain spectroscopic MRI for radiation therapy planning
$551,573Hyunsuk Shim · Emory University · U01 · FY2024 · CA
Resistance To Therapeutics Directed At The EGFR/Pi3-K Pathways In Glioblastoma
$551,569Webster Cavenee · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Control of Protein Translation in Cancer Pathogenesis
$551,327Sloan-Kettering Institute For Cancer Res · U01 · FY2005 · CA
MRI fluorescence tomography for quantifying tumor receptor concentration in vivo
$551,164Scott C Davis · Dartmouth College · R01 · FY2014 · CA
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging
$551,146Xingde Li · Johns Hopkins University · R01 · FY2016 · CA
MR Metabolic Imaging of Response to Targeted Therapies in GBM
$550,983Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2013 · CA
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)
$550,881Stephen W Byers · Georgetown University · R01 · FY2013 · CA
Targeting Go and Grow in Glioblastoma
$550,865Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2022 · NS
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$550,752Darell D Bigner · Duke University · P01 · FY2022 · CA
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
$550,632Jinyuan Zhou · Johns Hopkins University · R01 · FY2015 · CA